Revolutionizing Biotech: Dipal Doshi Joins Azenta’s Board of Directors
Dipal Doshi has been appointed to the Board of Directors at Azenta, Inc., marking a significant change in the company’s governance. His extensive experience in
Dipal Doshi has been appointed to the Board of Directors at Azenta, Inc., marking a significant change in the company’s governance. His extensive experience in
Disperazol Pharma partners with AMR Industry Alliance to combat antimicrobial resistance (AMR). Over 1.27 million deaths occur yearly due to AMR-related infections, highlighting the urgent
United Therapeutics plans to build a 22-acre facility in East Houston for breeding genetically modified pigs. The pigs are engineered to grow kidneys for human
In a bold move to transform cancer treatment, Commit Biologics A/S is securing funding to propel its innovative Bispecific Complement Engaging (BiCE™) platform. This groundbreaking
Exciting updates are sweeping through the world’s favorite theme parks! After an unexpected absence, the beloved elephant has made its triumphant return to the Jungle
Recent Movements in Sana Biotechnology’s Stock On Wednesday, Sana Biotechnology, Inc. saw its stock price soar by a remarkable 13.9%. The share value reached a
Transforming University Research into Economic Power The UK aims to position itself as a leading science and technology hub, fueling sustainable economic growth through university-developed
The AI Investment Revolution Artificial intelligence is no longer just a concept—it is rapidly becoming a core component of modern industries. With advancements manifesting across
Overview of Recent Trading Activity Sana Biotechnology, Inc. experienced a notable surge in its share price, climbing 13.9% on Wednesday. The stock peaked at $3.19
Unraveling the Surge in White Biotechnology The global white biotechnology market is witnessing a remarkable transformation, poised to expand from $425.76 billion in 2024 to